ReCerise Therapeutics Inc.is a bio-venture company that researches and develops
targeted therapies with the aim of specialized treatment for progressive liver diseases.
ReCerise is focused on R&D-oriented business development
and is comprised of leading experts in the fields of basic translation, medicinal research, and innovation.
We are focused on securing our original technologies based on the development of specialized treatments for diverse liver disease patients.